A study by researchers at the UBC Centre for Health Services and Policy Research that concluded that the practice of sex- and gender-based analysis has still not been “internalized” or “mainstreamed by the community of pharmaceutical policy researchers. The author’s state that “increased application of SGBA is, in most cases, not only appropriate for the topics under investigation, but well within the reach of today's pharmaceutical policy researchers.”
[7]